298
Views
7
CrossRef citations to date
0
Altmetric
Supplemental Issue: Spectrum of Uveitis in Asia PacificREVIEW ARTICLE

Epidemiology of Uveitis, Caused by HTLV-1, Toxoplasmosis, and Tuberculosis; the Three Leading Causes of Endemic Infectious Uveitis in Japan

, MD, PhD, , MD, PhD & , MD, PhD
Pages S19-S23 | Received 15 Apr 2016, Accepted 24 Oct 2016, Published online: 07 Dec 2016

REFERENCES

  • Kitamei H, Kitaichi N, Namba K, et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol. 2009;87:424–428.
  • Keino H, Nakashima C, Watanabe T, et al. Frequency and clinical features of intraocular inflammation in Tokyo. Clin Exp Ophthalmol. 2009;37:595–601.
  • Hikita S, Sonoda KH, Hijioka K, et al. Incidence of uveitis in the northern Kyushu region of Japan – comparison between the periods of 1996–2001 and 2003–2008. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc). 2012;116:847–855.
  • Miyanaga M, Shimizu K, Kawaguchi T, et al. Clinical survey of uveitis in HTLV-1 endemic region. Ocul Immunol Inflamm. 2009;17:335–341.
  • Ohguro N, Sonoda KH, Takeuchi M, et al. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432–435.
  • Verdonck K, Gonzalez E, Van Dooren S, et al. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7:266–281.
  • Watanabe T. Current status of HTLV-1 infection. Int J Hematol. 2011;94:430–434.
  • Kamoi K, Mochizuki M. HTLV-1 uveitis. Front Microbiol. 2012;3:1–4.
  • Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84:327–335.
  • Uchimaru K, Nakamura Y, Tojo A, et al. Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area. Int J Hematol. 2008;88:565–570.
  • Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol. 1992;66:2288–2295.
  • Ono A, Miura T, Araki S, et al. Subtype analysis of HTLV-1 in patients with HTLV-1 uveitis. Jpn J Cancer Res. 1994;85:767–770.
  • Nakao K, Ohba N, Nakagawa M, et al. Clinical course of HTLV-I-associated uveitis. Jpn J Ophthalmol. 1999;43:404–409.
  • Kase S, Namba K, Kitaichi N, et al. Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol. 2013;57:379–384.
  • Shibata K, Shimamoto Y, Nishimura T, et al. Ocular manifestations in adult T-cell leukemia/lymphoma. Ann Hematol. 1997;74:163–168.
  • Inaba S, Sato H, Okochi K, et al. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience. Transfusion. 1989;29:7–11.
  • Nerome Y, Kojyo K, Ninomiya Y, et al. Current human T-cell lymphotropic virus type 1 mother-to-child transmission prevention status in Kagoshima. Pediatr Int. 2014;56:640–643.
  • Maenz M, Schluter D, Liesenfeld O, et al. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res. 2014;39:77–106.
  • Holland GN. LX Edward Jackson Memorial Lecture: Ocular toxoplasmosis: a global reassessment. Part I; Epidemiology and course of disease. Am J Ophthalmol. 2003;136:973–988.
  • Pleyer U, Schlüter D, Mänz M. Ocular toxoplasmosis: recent aspects of pathophysiology and clinical implications. Ophthalmic Res. 2014;52:116–123.
  • Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–44.
  • Sakikawa M, Noda S, Hanaoka M, et al. Anti-toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,166 pregnant women in Japan. Clin Vaccine Immunol. 2012;19:365–367.
  • WHO. Global Tuberculosis Report. Geneva: World Health Organization; 2015.
  • Urayama A. Etiology of uveitis. Rinsho Ganka. 1960;14:1015–1021.
  • Shimouchi A, Ohmori M. City tuberculosis. Kekkaku. 2007;82:345.
  • Hoshino H, Uchimura K, Yamauchi Y. Comparison of TB incidence of young and middle age groups between urban/suburban prefectures and other prefectures. Kekkaku. 2009;84:1–8.
  • Cunningham ET, Rathinam SR, Albini TA, et al. Tuberculous uveitis. Ocul Immunol Inflamm. 2015;23:2–6.
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis – an update. Surv Ophthalmol. 2007;52:561–587.
  • Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology. 2002;109:851–857.
  • La Distia Nora R, van Velthoven ME, Ten Dam-van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157:754–761.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.